ConductScience.org, home

Paper41316355

Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature.

Chandrasekaran S and 7 others. J Med Case Rep, 2025. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature. Papers, record 41316355. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41316355

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Unraveling COVID-19-vaccination-induced bullous pemphigoid: a case report and review of the literature.
PubMed
Journal
J Med Case Rep
PubMed
Year
2025
PubMed
Publication types
Journal Article, Case Reports, Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-01-13
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chandrasekaran SSavitrihttps://orcid.org/0000-0001-9333-7080
2Kamboj MMamta
3Baddepudi SSnigdha
4Raj RRishuhttps://orcid.org/0009-0005-1798-0847
5Suresh CChaitanya
6Sanker VVivek
7Dave TTirthhttps://orcid.org/0000-0001-7935-7333
8Wijenaike NNishan

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pemphigoid, BullousMajor topic
COVID-19Major topic
COVID-19 VaccinesMajor topic
Humans
Male
Aged, 80 and over
SARS-CoV-2
BNT162 Vaccine
Vaccination
Diabetes Mellitus, Type 2

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136041291Autoimmune and autoinflammatory conditions after COVID-19 vaccination. New case reports and updated literature review.J Autoimmun2022https://conductscience.org/library/papers/36041291PubMed
236849670Mucous Membrane Pemphigoid Following the Administration of COVID-19 Vaccine.Head Neck Pathol2023https://conductscience.org/library/papers/36849670PubMed
336578130SARS-CoV-2 vaccine-triggered conversion from systemic lupus erythematosus (SLE) to bullous SLE and dipeptidyl peptidase 4 inhibitors-associated bullous pemphigoid.J Dermatol2023https://conductscience.org/library/papers/36578130PubMed
435141881SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.Int J Dermatol2022https://conductscience.org/library/papers/35141881PubMed
534292611Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.J Cutan Pathol2022https://conductscience.org/library/papers/34292611PubMed
634957554New-onset autoimmune phenomena post-COVID-19 vaccination.Immunology2022https://conductscience.org/library/papers/34957554PubMed
734275656Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination.J Allergy Clin Immunol2021https://conductscience.org/library/papers/34275656PubMed
834928518Bullous pemphigoid in a young male after COVID-19 mRNA vaccine: a report and brief literature review.J Eur Acad Dermatol Venereol2022https://conductscience.org/library/papers/34928518PubMed
936259862A new eruption of bullous pemphigoid following mRNA COVID-19 vaccination.Dermatol Online J2022https://conductscience.org/library/papers/36259862PubMed
1034606112Biphasic bullous pemphigoid starting after first dose and boosted by second dose of mRNA-1273 vaccine in an 84-year-old female with polymorbidity and polypharmacy.J Eur Acad Dermatol Venereol2022https://conductscience.org/library/papers/34606112PubMed
1134715347Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review.Clin Microbiol Infect2022https://conductscience.org/library/papers/34715347PubMed
1236744126Autoimmune bullous diseases during COVID-19 pandemic: 2022 update on rituximab and vaccine.Front Med (Lausanne)2023https://conductscience.org/library/papers/36744126PubMed
1338099105COVID-19 Vaccine-Triggered Bullous Pemphigoid: Two New Cases from Saudi Arabia.Indian J Dermatol2023https://conductscience.org/library/papers/38099105PubMed
1435073431Incident bullous pemphigoid in a psoriatic patient following mRNA-1273 SARS-CoV-2 vaccination.J Eur Acad Dermatol Venereol2022https://conductscience.org/library/papers/35073431PubMed
1533515320SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis.Rheumatol Int2021https://conductscience.org/library/papers/33515320PubMed
1635608483Bullous pemphigoid after inactivated COVID-19 vaccination: Case report.Dermatol Ther2022https://conductscience.org/library/papers/35608483PubMed
1735716105Cutaneous manifestations following COVID-19 vaccination: A report of 25 cases.Dermatol Ther2022https://conductscience.org/library/papers/35716105PubMed
1838483787Post COVID-19 vaccination medium vessel vasculitis: a systematic review of case reports.Infection2024https://conductscience.org/library/papers/38483787PubMed
1935887732Pemphigus during the COVID-19 Epidemic: Infection Risk, Vaccine Responses and Management Strategies.J Clin Med2022https://conductscience.org/library/papers/35887732PubMed
2037406312New-Onset Pemphigoid Gestationis Following COVID-19 Vaccination.Cutis2023https://conductscience.org/library/papers/37406312PubMed

See all 39 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41316355

GET https://conductscience.org/api/papers/v1/41316355/references?page=2